Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „There“
Suchtreffer
Begriffe & Kennungen
Baraclude · 4.8 · Gender/age: there was no apparent difference in the safety profile of entecavir with respect to gender ( 25%
Eintrag öffnenBavencio · 4.5 · Avelumab is primarily metabolised through catabolic pathways, therefore, it is not expected that avelumab will
Eintrag öffnenBavencio · 4.8 · Immune checkpoint inhibitor class effects There have been cases of the following adverse reactions reported du
Eintrag öffnenBekemv · 4.8 · Antibodies to eculizumab were detected in patients with PNH and aHUS. As with all proteins there is a potentia
Eintrag öffnenBemrist Breezhaler · 4.5 · Beta-adrenergic blockers may weaken or antagonise the effect of beta2-adrenergic agonists. Therefore, this med
Eintrag öffnenBeneFIX · 4.8 · There are insufficient data to provide information on inhibitor incidence in PUPs (see also section 5.1).
Eintrag öffnenBeneFIX · 4.8 · There is a potential risk of thromboembolic episodes following the administration of factor IX products, see s
Eintrag öffnenBenepali · 4.8 · Pancytopenia and aplastic anaemia There have been post-marketing reports of pancytopenia and aplastic anaemia,
Eintrag öffnenBenepali · 4.8 · There have been rare reports of patients, including rheumatoid factor positive patients, who have developed ot
Eintrag öffnenBenepali · 4.8 · There have been rare reports of patients, including rheumatoid factor positive patients, who have developed ot
Eintrag öffnenBenepali · 4.8 · There were 4 reports of macrophage activation syndrome in juvenile idiopathic arthritis clinical trials.
Eintrag öffnenBenepali · 4.8 · There were 4 reports of macrophage activation syndrome in juvenile idiopathic arthritis clinical trials.
Eintrag öffnenBenepali · 4.8 · There were no differences in rates of infection among patients treated with etanercept and those treated with
Eintrag öffnenBenepali · 4.8 · There were no differences in rates of infection among patients treated with etanercept and those treated with
Eintrag öffnenBeovu · 4.8 · Immunogenicity There is a potential for an immune response in patients treated with Beovu.
Eintrag öffnenBeovu · 4.8 · Product-class-related adverse reactions There is a theoretical risk of arterial thromboembolic events, includi
Eintrag öffnenBesponsa · 4.5 · In patients receiving inotuzumab ozogamicin, prolonged QT interval was observed (see section 4.4). Therefore,
Eintrag öffnenBesremi · 4.5 · Therefore, care should be taken when ropeginterferon alfa-2b is co- substrates notably those having a narrow t
Eintrag öffnenBeyfortus · 4.5 · There is limited experience of co-administration with vaccines. In clinical trials, when nirsevimab was given
Eintrag öffnenBiResp Spiromax · 4.5 · There is an elevated risk of arrhythmias in patients receiving concomitant anaesthesia with halogenated hydroc
Eintrag öffnen